^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AM-5992

    i
    Other names: AM-5992, AM 5992
    Associations

    News

    Trials
    Company:
    Amgen
    Drug class:
    CDK4 inhibitor, FLT3 inhibitor
    Related drugs:
    Associations

    News

    Trials
    over1year
    FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with mA Modification and Necroptosis. (PubMed, Genes (Basel))
    Finally, FERMT1 overexpression may be sensitive to chemotherapy drugs such as Palbociclib, AM-5992 and TAE-226. FERMT1 can serve as a diagnostic and prognostic marker of PAAD, which is connected with immune cell infiltration and the modulation of mA and necroptosis.
    Journal
    |
    FERMT1 (Fermitin Family Member 1)
    |
    FERMT1 expression
    |
    Ibrance (palbociclib) • AM-5992 • NVP-TAE226